Human breast cancer is associated with a loss of heterozygosity or mutation of the PTEN gene, and decreased PTEN expression is associated with invasive breast cancer and poor prognosis (Singh et al, 1998; Garcia et al, 1999). Here, PTEN is linked to breast carcinoma.